Relative to Pancreatic Cancer Awareness Month.
SR 62 serves to bring state attention to the significant disparities in funding for pancreatic cancer research compared to other leading cancers. The resolution highlights that, despite the grave statistics and low survival rates, funding for pancreatic cancer research from the National Cancer Institute has been disproportionately low, with just over 3% of the NCI's budget allocated to this disease. By declaring a month dedicated to awareness, the resolution aims to advocate for more comprehensive research efforts that could lead to improved outcomes for patients diagnosed with pancreatic cancer.
Senate Resolution No. 62, introduced by Senator Valladares, aims to raise awareness about pancreatic cancer by proclaiming November 2025 as Pancreatic Cancer Awareness Month in California. This resolution follows alarming statistics concerning pancreatic cancer, which is one of the deadliest cancers in the United States, with a low five-year survival rate of only 13%. The bill underscores the necessity for increased awareness and research funding to improve early detection and treatment options that could potentially save lives.
The sentiment around SR 62 is largely supportive, recognizing the dire need for action regarding pancreatic cancer awareness and research. Many legislators and organizations advocate for more substantial investments in this field. The overall tone is one of urgent advocacy, with calls to action directed at both lawmakers and the public to enhance awareness about the disease and push for more funding and research initiatives.
While the resolution itself is generally non-controversial, the broader issue of funding for cancer research presents points of contention, particularly when comparing the attention and resources allocated to pancreatic cancer versus other cancers. The resolution invites discussions about healthcare priorities and the necessity of improving research funding to address the growing epidemic of pancreatic cancer, which remains significantly underfunded relative to its mortality rate.